https://edrn.cancer.gov/data-and-resources/miscellaneous-resources/ncbi-gene-entry-for-human-dsg2/
NCBI Gene entry for human DSG2
This is a miscellaneous resource located at https://www.ncbi.nlm.nih.gov/gene/1829
for humanncbigeneentry
https://edrn.cancer.gov/data-and-resources/miscellaneous-resources/genecards-entry-for-human-dsg2/
GeneCards entry for human DSG2
This is a miscellaneous resource located at https://www.genecards.org/cgi-bin/carddisp.pl?gene=DSG2
for humanentry
https://edrn.cancer.gov/data-and-resources/biomarkers/dsg2/
DSG2
DSG2 is a biomarker being researched by EDRN
https://www.mdpi.com/1999-4915/14/8/1835
Properties of Adenovirus Vectors with Increased Affinity to DSG2 and the Potential Benefits of...
Carcinomas are characterized by a widespread upregulation of intercellular junctions that create a barrier to immune response and drug therapy. Desmoglein 2...
https://pubmed.ncbi.nlm.nih.gov/40316058/
DSG2 attenuates gemcitabine efficacy through PTX3 in lung adenocarcinoma
Lung adenocarcinoma (LUAD) is the most prevalent subtype of lung cancer, often diagnosed at an advanced stage with poor prognosis and limited treatment...
gemcitabineefficacylungadenocarcinoma